Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Check the trial phase
Stable for ~1 month
Secondary outcome measurements included reduction in body weight from baseline by at least 5% or 10% by week 26, changes in waist circumference, total cholesterol, HDL, LDL, VLDL, and triglycerides, and levels of different glycemic variables including HbA1C, fasting plasma glucose, fasting insulin, insulin resistance, and the functioning of beta-cells
Conclusion Lupus anticoagulant is a condition that can lead to serious health issues due to an increased risk of blood clotting
US$ 23.30
US$ 21.72
US$ 25.59
